Steroid Hormones and Receptors in Health and Disease: A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021

Matthias Barton; Daniel E. Frigo; Zeynep Madak-Erdogan; Franck Mauvais-Jarvis; Eric R. Prossnitz

doi:10.1096/fj.202101228

Steroid Hormones and Receptors in Health and Disease: A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021

Matthias Barton, Daniel E. Frigo, Zeynep Madak-Erdogan, Franck Mauvais-Jarvis, Eric R. Prossnitz

Cancer Systems Imaging

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Article number	e21858
Journal	FASEB Journal
Volume	35
Issue number	11
DOIs	https://doi.org/10.1096/fj.202101228
State	Published - Nov 2021

Keywords

GR
MR
VDR
aldosterone
androgens
estradiol
estrogen
glucocorticoids
nuclear receptors
progesterone
thyroid hormone
vitamin D

ASJC Scopus subject areas

Biotechnology
Biochemistry
Molecular Biology
Genetics

Access to Document

10.1096/fj.202101228

Cite this

Steroid Hormones and Receptors in Health and Disease: A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021. / Barton, Matthias; Frigo, Daniel E.; Madak-Erdogan, Zeynep et al.
In: FASEB Journal, Vol. 35, No. 11, e21858, 11.2021.

Research output: Contribution to journal › Article › peer-review

@article{a0367e1121184e48b3fce7929eb56620,

title = "Steroid Hormones and Receptors in Health and Disease: A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021",

keywords = "GR, MR, VDR, aldosterone, androgens, estradiol, estrogen, glucocorticoids, nuclear receptors, progesterone, thyroid hormone, vitamin D",

author = "Matthias Barton and Frigo, {Daniel E.} and Zeynep Madak-Erdogan and Franck Mauvais-Jarvis and Prossnitz, {Eric R.}",

note = "Funding Information: The authors extend special thanks to FASEB for their assistance throughout the organization of this conference, especially Andrea Bauerfeind for her support with organizing the online conference. The authors also thank Silvy Song, their FASEB conference manager, for her hard work in ensuring a well‐organized and smoothly run meeting, as well as Bahara Saleh, who was instrumental in coordinating the meeting's sponsors and finances. They also thank Paul Mermelstein, who helped plan initial stages of the meeting. Finally, they thank their sponsors for their maintained support throughout the COVID‐19 pandemic, as well as the US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) and National Cancer Institute (NCI) for providing generous support for the conference (R13 DK126171). This conference was supported by generous contributions from FASEB, Dr Paul J. Davis (Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA), the University of Illinois Urbana‐Champaign (Urbana, IL, USA), the University of New Mexico (Albuquerque. NM, USA), Tulane University (New Orleans, LA, USA), AbbVie (Lake Bluff, IL, USA), Pfizer (New York, NY, USA), and the journals (American Association for the Advancement of Science, Washington, DC, USA), the (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA), (Elsevier, Amsterdam, The Netherlands), the (John Wiley & Sons, Hoboken, NJ, USA), and (Society for Endocrinology, North Bristol, UK). This conference was supported by grant R13 DK126171 from NIH/NIDDK and NCI. M. Barton is supported by the Swiss National Science Foundation (grants 108 258 and 122 504); D. E. Frigo is funded by NIH (grants R01CA184208 and P50CA140388); Z. Madak‐Erdogan is funded by the US Department of Agriculture/National Institute of Food and Agriculture (grants ILLU‐698‐331 and ILLU‐698‐924); F. Mauvais‐Jarvis is funded by NIH (grants DK107444 and DK074970) and a US Department of Veterans Affairs Merit Award (BX003725); and E. R. Prossnitz is supported by NIH (grants R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176) and Dialysis Clinic, Inc (Nashville, TN, USA; grant RF#C3937). The views expressed in written conference materials or publications and by organizers, speakers, and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government. Science Signaling Journal of Biological Chemistry Steroids Journal of Neuroendocrinology Endocrine‐Related Cancer Funding Information: The authors extend special thanks to FASEB for their assistance throughout the organization of this conference, especially Andrea Bauerfeind for her support with organizing the online conference. The authors also thank Silvy Song, their FASEB conference manager, for her hard work in ensuring a well-organized and smoothly run meeting, as well as Bahara Saleh, who was instrumental in coordinating the meeting's sponsors and finances. They also thank Paul Mermelstein, who helped plan initial stages of the meeting. Finally, they thank their sponsors for their maintained support throughout the COVID-19 pandemic, as well as the US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) and National Cancer Institute (NCI) for providing generous support for the conference (R13 DK126171). This conference was supported by generous contributions from FASEB, Dr Paul J. Davis (Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA), the University of Illinois Urbana-Champaign (Urbana, IL, USA), the University of New Mexico (Albuquerque. NM, USA), Tulane University (New Orleans, LA, USA), AbbVie (Lake Bluff, IL, USA), Pfizer (New York, NY, USA), and the journals Science Signaling (American Association for the Advancement of Science, Washington, DC, USA), the Journal of Biological Chemistry (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA), Steroids (Elsevier, Amsterdam, The Netherlands), the Journal of Neuroendocrinology (John Wiley & Sons, Hoboken, NJ, USA), and Endocrine-Related Cancer (Society for Endocrinology, North Bristol, UK). This conference was supported by grant R13 DK126171 from NIH/NIDDK and NCI. M. Barton is supported by the Swiss National Science Foundation (grants 108 258 and 122 504); D. E. Frigo is funded by NIH (grants R01CA184208 and P50CA140388); Z. Madak-Erdogan is funded by the US Department of Agriculture/National Institute of Food and Agriculture (grants ILLU-698-331 and ILLU-698-924); F. Mauvais-Jarvis is funded by NIH (grants DK107444 and DK074970) and a US Department of Veterans Affairs Merit Award (BX003725); and E. R. Prossnitz is supported by NIH (grants R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176) and Dialysis Clinic, Inc (Nashville, TN, USA; grant RF#C3937). The views expressed in written conference materials or publications and by organizers, speakers, and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.",

year = "2021",

month = nov,

doi = "10.1096/fj.202101228",

language = "English (US)",

volume = "35",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "FASEB",

number = "11",

}

TY - JOUR

T1 - Steroid Hormones and Receptors in Health and Disease

T2 - A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021

AU - Barton, Matthias

AU - Frigo, Daniel E.

AU - Madak-Erdogan, Zeynep

AU - Mauvais-Jarvis, Franck

AU - Prossnitz, Eric R.

N1 - Funding Information: The authors extend special thanks to FASEB for their assistance throughout the organization of this conference, especially Andrea Bauerfeind for her support with organizing the online conference. The authors also thank Silvy Song, their FASEB conference manager, for her hard work in ensuring a well‐organized and smoothly run meeting, as well as Bahara Saleh, who was instrumental in coordinating the meeting's sponsors and finances. They also thank Paul Mermelstein, who helped plan initial stages of the meeting. Finally, they thank their sponsors for their maintained support throughout the COVID‐19 pandemic, as well as the US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) and National Cancer Institute (NCI) for providing generous support for the conference (R13 DK126171). This conference was supported by generous contributions from FASEB, Dr Paul J. Davis (Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA), the University of Illinois Urbana‐Champaign (Urbana, IL, USA), the University of New Mexico (Albuquerque. NM, USA), Tulane University (New Orleans, LA, USA), AbbVie (Lake Bluff, IL, USA), Pfizer (New York, NY, USA), and the journals (American Association for the Advancement of Science, Washington, DC, USA), the (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA), (Elsevier, Amsterdam, The Netherlands), the (John Wiley & Sons, Hoboken, NJ, USA), and (Society for Endocrinology, North Bristol, UK). This conference was supported by grant R13 DK126171 from NIH/NIDDK and NCI. M. Barton is supported by the Swiss National Science Foundation (grants 108 258 and 122 504); D. E. Frigo is funded by NIH (grants R01CA184208 and P50CA140388); Z. Madak‐Erdogan is funded by the US Department of Agriculture/National Institute of Food and Agriculture (grants ILLU‐698‐331 and ILLU‐698‐924); F. Mauvais‐Jarvis is funded by NIH (grants DK107444 and DK074970) and a US Department of Veterans Affairs Merit Award (BX003725); and E. R. Prossnitz is supported by NIH (grants R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176) and Dialysis Clinic, Inc (Nashville, TN, USA; grant RF#C3937). The views expressed in written conference materials or publications and by organizers, speakers, and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government. Science Signaling Journal of Biological Chemistry Steroids Journal of Neuroendocrinology Endocrine‐Related Cancer Funding Information: The authors extend special thanks to FASEB for their assistance throughout the organization of this conference, especially Andrea Bauerfeind for her support with organizing the online conference. The authors also thank Silvy Song, their FASEB conference manager, for her hard work in ensuring a well-organized and smoothly run meeting, as well as Bahara Saleh, who was instrumental in coordinating the meeting's sponsors and finances. They also thank Paul Mermelstein, who helped plan initial stages of the meeting. Finally, they thank their sponsors for their maintained support throughout the COVID-19 pandemic, as well as the US National Institutes of Health (NIH)/National Institute of Diabetes and Digestive Diseases (NIDDK) and National Cancer Institute (NCI) for providing generous support for the conference (R13 DK126171). This conference was supported by generous contributions from FASEB, Dr Paul J. Davis (Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Albany, NY, USA), the University of Illinois Urbana-Champaign (Urbana, IL, USA), the University of New Mexico (Albuquerque. NM, USA), Tulane University (New Orleans, LA, USA), AbbVie (Lake Bluff, IL, USA), Pfizer (New York, NY, USA), and the journals Science Signaling (American Association for the Advancement of Science, Washington, DC, USA), the Journal of Biological Chemistry (American Society for Biochemistry and Molecular Biology, Rockville, MD, USA), Steroids (Elsevier, Amsterdam, The Netherlands), the Journal of Neuroendocrinology (John Wiley & Sons, Hoboken, NJ, USA), and Endocrine-Related Cancer (Society for Endocrinology, North Bristol, UK). This conference was supported by grant R13 DK126171 from NIH/NIDDK and NCI. M. Barton is supported by the Swiss National Science Foundation (grants 108 258 and 122 504); D. E. Frigo is funded by NIH (grants R01CA184208 and P50CA140388); Z. Madak-Erdogan is funded by the US Department of Agriculture/National Institute of Food and Agriculture (grants ILLU-698-331 and ILLU-698-924); F. Mauvais-Jarvis is funded by NIH (grants DK107444 and DK074970) and a US Department of Veterans Affairs Merit Award (BX003725); and E. R. Prossnitz is supported by NIH (grants R01 CA163890, R01 CA194496, P30 CA118100, P20 GM121176) and Dialysis Clinic, Inc (Nashville, TN, USA; grant RF#C3937). The views expressed in written conference materials or publications and by organizers, speakers, and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.

PY - 2021/11

Y1 - 2021/11

KW - GR

KW - MR

KW - VDR

KW - aldosterone

KW - androgens

KW - estradiol

KW - estrogen

KW - glucocorticoids

KW - nuclear receptors

KW - progesterone

KW - thyroid hormone

KW - vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85118157196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118157196&partnerID=8YFLogxK

U2 - 10.1096/fj.202101228

DO - 10.1096/fj.202101228

M3 - Article

C2 - 34634152

AN - SCOPUS:85118157196

SN - 0892-6638

VL - 35

JO - FASEB Journal

JF - FASEB Journal

IS - 11

M1 - e21858

ER -

Steroid Hormones and Receptors in Health and Disease: A Research Conference Co-Organized by FASEB and the International Committee on Rapid Responses to Steroid Hormones (RRSH), May 25-27, 2021

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this